|
Neonatal Intensive Care Drug Manual
|
| bet | 535/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Contraindications
|
Resonium A and Calcium Resonium should not be administered orally to neonates and is contraindicated in neonates with reduced gut motility (e.g. post-operatively or drug induced).(2)
History of hypersensitivity to polystyrene sulfonate resins.
Serum potassium levels less than 5 mmol/L.
Obstructive bowel disease.
|
Precautions
|
Hypercalcaemia, hyperparathyroidism: avoid calcium resin.
Congestive heart failure, hypernatraemia, sodium overload: avoid sodium resin
|
Drug interactions
|
Not applicable
|
Adverse reactions
|
Electrolyte imbalances: Hypokalaemia, hypernatraemia, hypocalcaemia, hypercalcaemia, hypomagnesaemia
Water overload
Gastrointestinal: Perforation, haemorrhage, necrotising enterocolitis
|
Compatibility
|
Not applicable
|
Incompatibility
|
Not applicable
|
Stability
|
Suspensions of the resin should be freshly prepared and not stored beyond 24 hours.
Once reconstituted, Resonium A and Calcium Resonium is a cream to light brown coloured suspension in which small white particulates may remain visible.
|
Storage
|
Store below 30°C.
|
Excipients
|
Resonium A and Calcium Resonium: Saccharin sodium and vanillin.
|
|
|
| |
